Jones Financial Companies’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Sell
111,593
-3,734
-3% -$387K ﹤0.01% 880
2026
Q1
$11.3M Buy
115,327
+114,329
+11,456% +$11.7M 0.01% 783
2025
Q4
$106K Buy
998
+16
+2% +$1.85K ﹤0.01% 2199
2025
Q3
$124K Buy
982
+295
+43% +$35.1K ﹤0.01% 1990
2025
Q2
$84K Buy
687
+332
+94% +$37.9K ﹤0.01% 2006
2025
Q1
$35.8K Buy
355
+253
+248% +$24.7K ﹤0.01% 2190
2024
Q4
$9.42K Buy
102
+68
+200% +$6.68K ﹤0.01% 2546
2024
Q3
$3.29K Sell
34
-15
-31% -$1.35K ﹤0.01% 2555
2024
Q2
$4.2K Buy
+49
New +$4.11K ﹤0.01% 1981
2024
Q1
Sell
-23
Closed -$1.53K 1389
2023
Q4
$1.53K Buy
+23
New +$1.49K ﹤0.01% 929
2021
Q2
Sell
-576
Closed -$38K 672
2021
Q1
$38K Buy
+576
New +$37.6K ﹤0.01% 385

Other funds holding EHC

Jones Financial Companies's EHC Position: Q2 2026 in Review

Jones Financial Companies reduced its Encompass Health (EHC) stake by 3.2% in Q2 2026, selling an estimated $387K and leaving 111,593 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Jones Financial Companies first reported a position in EHC in Q1 2021 and has held it in 11 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Jones Financial Companies held 111,593 shares of Encompass Health worth $11.3M as of Q2 2026.
  • Jones Financial Companies sold 3,734 Encompass Health shares in Q2 2026, an estimated $387K.
  • Encompass Health made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #880 holding.
  • Jones Financial Companies first reported a position in Encompass Health in Q1 2021 and has held it in 11 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.